Stay updated with breaking news from Timothys Ernst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday. Several other analysts have also issued reports on BIO. Wells Fargo & Company cut their price objective on Bio-Rad Laboratories from $550.00 […]
Rowland & Co. Investment Counsel ADV lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 16.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 1,227 shares of the medical research company’s stock after selling 235 shares during the quarter. Rowland & Co. Investment Counsel ADV’s holdings in Bio-Rad Laboratories […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings results on Thursday. The medical research company reported $2.33 EPS for the quarter, missing the consensus estimate of $2.87 by ($0.54), Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 5.86% and a positive return on equity of 3.82%. The firm had revenue […]
Tobam acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 150 shares of the medical research company’s stock, valued at approximately $57,000. A number of other institutional investors also […]
Tobam purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 150 shares of the medical research company’s stock, valued at approximately $57,000. Other large investors have also modified their holdings of the company. Desjardins Global Asset Management Inc. bought a new stake in […]